1174524-47-0 Usage
Uses
Used in Organic Synthesis:
(1R)-1-([(2,5-dioxopyrrolidin-1-yl)oxy]carbonyloxy)ethyl 2-methylpropionate is used as a synthetic intermediate for the creation of more complex organic molecules. Its unique functional groups and reactivity make it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (1R)-1-([(2,5-dioxopyrrolidin-1-yl)oxy]carbonyloxy)ethyl 2-methylpropionate is used as a key component in the development of new drugs. Its potential biological activity and ability to form stable derivatives with therapeutic agents make it a promising candidate for drug discovery and medicinal chemistry.
Used in Materials Science:
(1R)-1-([(2,5-dioxopyrrolidin-1-yl)oxy]carbonyloxy)ethyl 2-methylpropionate is utilized in materials science for the development of novel materials with specific properties. Its versatility in forming different types of chemical linkages allows it to contribute to the creation of advanced materials with applications in various industries, such as coatings, adhesives, and polymers.
Check Digit Verification of cas no
The CAS Registry Mumber 1174524-47-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,4,5,2 and 4 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1174524-47:
(9*1)+(8*1)+(7*7)+(6*4)+(5*5)+(4*2)+(3*4)+(2*4)+(1*7)=150
150 % 10 = 0
So 1174524-47-0 is a valid CAS Registry Number.
1174524-47-0Relevant articles and documents
AZETIDINE DERIVATIVE, AND PRODRUG THEREOF
-
Paragraph 0204-0206, (2021/04/16)
An object of the present invention is to provide a compound useful as a therapeutic or prophylactic drug for a disease involving the immune system, by suppressing a function of immune cells by suppressing proliferation of activated T cells or suppressing production of interferon alpha (IFN-α) by activated plasmacytoid dendritic cells (pDC), particularly an autoimmune disease such as systemic lupus erythematosus (SLE) and lupus nephritis in SLE patients. The present invention provides a compound represented by general formula (I) : [wherein X, R1, R2, R3, R4, R5 and R6 are as described in the description], or a pharmaceutically acceptable salt thereof.
MESOPHASIC FORMS OF (3S)-AMINOMETHYL-5-METHYL-HEXANOIC ACID PRODRUGS AND METHODS OF USE
-
Page/Page column 5; 23, (2009/08/14)
Mesophasic forms of (3S)-aminomethyl-5-hexanoic acid prodrugs and methods of preparing and methods of using mesophasic forms of (3S)-aminomethyl-5-hexanoic acid prodrugs are provided.
